On January 27, Trevena Inc. (TRVN) declared the acceptance of NDA submission for oliceridine injection by China NMPA. Following the announcement, the stock became bullish
In after-hours trading, shares of Trevena Inc. (TRVN) were down -12.76% on Friday. The stock closed the previous trading session up 2.62% or $0.05 at
The shares of Trevena Inc. (TRVN) were up 6.44% in premarket trading at $2.15. TRVN stock closed at $2.02 yesterday, down -8.18% or $0.18. TRVN
The biotech industry is considered to be an attractive industry for the investor. This industry is continuously adopting new technological advancements. As time passes by
Investors are always looking for safe and secure investments and as a strong and profitable industry, the biotechnology industry is considered to be an attractive
Biotechnology is considered to be the backbone of many industrial sectors and it makes a significant contribution to the well being of society. Every single
The markets are up this morning driven by positive news on the economy and a possible COVID-19 vaccine. Over the weekend, president Trump announced that
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.